46 results
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
satisfaction with the aesthetic results of our products.
In order to generate repeat business from consumers, our consumers must be satisfied … to such payers’ satisfaction. Such studies might require us to commit a significant amount of management time and financial and other resources. Our
8-K
EX-10.1
CTCX
Carmell Corp - Ordinary Shares
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Subject to satisfaction of the covenants and conditions
8-K
EX-10.1
tufs6a00jcv 3e58l
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K
EX-99.1
fkz uoqrtcla8e
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K/A
EX-99.2
bngkzc v1tq
14 Aug 23
Completion of Acquisition or Disposition of Assets
5:55pm
8-K
EX-3.1
77drcgu8kdsahxhi
14 Aug 23
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity
7:01am
8-K
EX-10.1
g7xqdm7vtquqe
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
8-K
vne5a9l2gd 8zp
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
8-K
EX-99.2
t7sl4eml0d9 pp
20 Jul 23
Entry into a Material Definitive Agreement
5:21pm
425
do300ell3emwcjx7
27 Jun 23
Business combination disclosure
8:28am
8-K
EX-99.1
fojy56y3sgn2f
27 Jun 23
Other Events
8:26am
424B3
ix2ayb0z
23 Jun 23
Prospectus supplement
4:47pm